Increased plasma levels of interleukin-6 (IL-6) in response to acute hypoglycemia have been well documented. Aiming to study the interaction between IL-6 and counter-regulatory hormones during hypoglycemic stress we conducted an exploratory single center study involving 26 adult patients undergoing insulin tolerance test. Insulin-induced hypoglycemia elicited a significant dynamic response of IL-6, adrenaline, noradrenaline, GH, prolactin, ACTH and serum and salivary cortisol (P < 0.001 for all variables). Patients with insufficient HPA axis response had lower hypoglycemia-induced IL-6 increase (median: 0.88 pg/mL) compared with individuals with intact HPA axis response (2.03 pg/mL, P = 0.007). IL-6 maximal increase correlated with the maximal increase of serum cortisol (r = 0.48; P = 0.013), salivary cortisol (r = 0.66; P = 0.012), plasma ACTH (r = 0.48; P = 0.013) and with the increase in procedure-related symptoms of anxiety and hypoglycemia (r = 0.57; P = 0.003). In conclusion, hypoglycemic stress-induced IL-6 increase is associated with activation of the HPA axis, suggesting that IL-6 response to hypoglycemic stress may be regarded as part of the counter-regulatory response, possibly contributing to the maintenance of glucose homeostasis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2020.577446DOI Listing

Publication Analysis

Top Keywords

insulin-induced hypoglycemia
8
interleukin-6 response
4
response insulin-induced
4
hypoglycemia associated
4
associated hypothalamic-pituitary-adrenal
4
hypothalamic-pituitary-adrenal axis
4
axis activation
4
activation increased
4
increased plasma
4
plasma levels
4

Similar Publications

Supramolecular Peptide Depots for Glucose-Responsive Glucagon Delivery.

J Biomed Mater Res A

January 2025

Department of Chemical & Biomolecular Engineering, University of Notre Dame, Notre Dame, USA.

Precise blood glucose control continues to be a critical challenge in the treatment and management of type 1 diabetes in order to mitigate both acute and chronic complications. This study investigates the development of a supramolecular peptide amphiphile (PA) material functionalized with phenylboronic acid (PBA) for glucose-responsive glucagon delivery. The PA-PBA system self-assembles into nanofibrillar hydrogels in the presence of physiological glucose levels, resulting in stable hydrogels capable of releasing glucagon under hypoglycemic conditions.

View Article and Find Full Text PDF

Michael Somogyi (Somogyi Mihály, 1883-1971) was a Hungarian biochemist who developed his scientific career in Europe and, primarily, the United States. He gave the name to the eponymous Somogyi effect or Somogyi hypothesis (in short, rebound hyperglycemia after insulin-induced hypoglycemia, particularly nocturnal), which was an axiom in the treatment of diabetes for decades. Although it is currently debated whether the Somogyi hypothesis is a real or relevant phenomenon in patients with diabetes, Somogyi's other significant career achievements are often overlooked.

View Article and Find Full Text PDF

We report the case of a patient with type 2 diabetes mellitus (T2DM) on insulin therapy with a history of recurrent and severe hypoglycemia related to lipodystrophy with an uncommon clinical presentation. This was the case of a 67-year-old female with type 2 diabetes hospitalized for the exploration and management of severe and recurrent hypoglycemia. Her diabetes has been evolving since the age of 40 years and was complicated by minimal retinopathy.

View Article and Find Full Text PDF

A Glucose-Responsive Glucagon-Micelle for the Prevention of Hypoglycemia.

ACS Cent Sci

November 2024

Department of Chemistry and Biochemistry, University of California, Los Angeles, 607 Charles E. Young Drive East, Los Angeles, California 90095-1569, United States.

While glucose-responsive insulin delivery systems are in widespread clinical use to treat insulin insufficiency, the on-demand supplementation of glucagon for acute hypoglycemia treatment remains understudied. A self-regulated glucagon release material is highly desired to mitigate the potential risks of severe insulin-induced hypoglycemia. Here, we describe a glucose-responsive polymeric nanosystem with glucagon covalently grafted to the end-group.

View Article and Find Full Text PDF

Impact of sweet drink on pituitary response and subject comfort during insulin tolerance test.

Sci Rep

December 2024

Department of Endocrinology, Hôpital Universitaire de Bruxelles (H.U.B.), CUB Hôpital Erasme, Université Libre de Bruxelles (ULB), Route de Lennik 808, 1070, Brussels, Belgium.

Article Synopsis
  • The insulin tolerance test (ITT) is crucial for diagnosing cortisol and growth hormone deficiencies, but there's debate on whether to give carbohydrates to patients once hypoglycemia occurs.
  • A study with 15 participants compared the effects of normal Cola vs. Cola Zero during ITT and found that normal Cola significantly reduced hypoglycemia duration and improved patient comfort.
  • Although sugar did not alter cortisol and growth hormone peaks, it did enhance recovery from low glucose levels and relief from hypoglycemia symptoms, reinforcing the idea that addressing hypoglycemia quickly is beneficial for patient comfort.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!